UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The BIG 2.04 MRC/EORTC SUPREMO Trial: pathology quality assurance of a large phase 3 randomised international clinical trial of postmastectomy radiotherapy in intermediate-risk breast cancer

Breast cancer research and treatment, 2017-05, Vol.163 (1), p.63-69

2017

Volltextzugriff (PDF)

Observer variation in immunohistochemical analysis of protein expression, time for a change?

Histopathology, 2006-06, Vol.48 (7), p.787-794

2006

Volltextzugriff (PDF)

Prognostic value of protein tyrosine kinase 6 (PTK6) for long-term survival of breast cancer patients

British journal of cancer, 2008-10, Vol.99 (7), p.1089-1095

2008

Volltextzugriff (PDF)

Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer

British journal of cancer, 2003-08, Vol.89 (3), p.552-556

2003

Volltextzugriff (PDF)

HER2 Gene Amplification in Breast Cancer: A Rogues' Gallery of Challenging Diagnostic Cases: UKNEQAS Interpretation Guidelines and Research Recommendations

American journal of clinical pathology, 2012-04, Vol.137 (4), p.595-605

2012

Volltextzugriff (PDF)

HER2 testing in the UK: further update to recommendations

Journal of clinical pathology, 2008-07, Vol.61 (7), p.818-824

2008

Volltextzugriff (PDF)

Phosphorylation of the androgen receptor is associated with reduced survival in hormone-refractory prostate cancer patients

British journal of cancer, 2008-03, Vol.98 (6), p.1094-1101

2008

Volltextzugriff (PDF)

Cardiac safety, efficacy, and correlation of serial serum HER2-extracellular domain shed antigen measurement with the outcome of the combined trastuzumab plus CMF in women with HER2-positive metastatic breast cancer: results from the EORTC 10995 phase II study

Breast cancer research and treatment, 2017-06, Vol.163 (3), p.507-515

2017

Volltextzugriff (PDF)

A UK NEQAS ISH Multicenter Ring Study Using the Ventana HER2 Dual-Color ISH Assay

American journal of clinical pathology, 2011, Vol.135 (1), p.157-162

2011

Volltextzugriff (PDF)

PTK (protein tyrosine kinase)-6 and HER2 and 4, but not HER1 and 3 predict long-term survival in breast carcinomas

British journal of cancer, 2007-03, Vol.96 (5), p.801-807

2007

Volltextzugriff (PDF)

Time dependence of biomarkers: non-proportional effects of immunohistochemical panels predicting relapse risk in early breast cancer

British journal of cancer, 2014-12, Vol.111 (12), p.2242-2247

2014

Volltextzugriff (PDF)

Chromogenic In Situ Hybridization: A Multicenter Study Comparing Silver In Situ Hybridization With FISH

American journal of clinical pathology, 2009-10, Vol.132 (4), p.514-520

2009

Volltextzugriff (PDF)

Tamoxifen resistance in early breast cancer: statistical modelling of tissue markers to improve risk prediction

British journal of cancer, 2010-05, Vol.102 (10), p.1503-1510

2010

Volltextzugriff (PDF)

Lymphocyte density determined by computational pathology validated as a predictor of response to neoadjuvant chemotherapy in breast cancer: secondary analysis of the ARTemis trial

Annals of oncology, 2017-08, Vol.28 (8), p.1832-1835

2017

Volltextzugriff (PDF)

Multimodal Biomarkers That Predict the Presence of Gleason Pattern 4: Potential Impact for Active Surveillance

The Journal of urology, 2023-08, Vol.210 (2), p.257-271

2023

Volltextzugriff (PDF)

Disease-free and overall survival at 3.5 years for neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide, for women with HER2 negative early breast cancer: ARTemis Trial

Annals of oncology, 2017-08, Vol.28 (8), p.1817-1824

2017

Volltextzugriff (PDF)

Genetic alterations of CCND1 and EMSY in breast cancers

Histopathology, 2008-05, Vol.52 (6), p.698-705

2008

Volltextzugriff (PDF)

Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer

British journal of cancer, 2006-01, Vol.94 (2), p.227-230

2006

Volltextzugriff (PDF)

HER2 testing in the UK: recommendations for breast and gastric in-situ hybridisation methods

Journal of clinical pathology, 2011-08, Vol.64 (8), p.649-653

2011

Volltextzugriff (PDF)

Discrepancies in central review re-testing of patients with ER-positive and HER2-negative breast cancer in the OPTIMA prelim randomised clinical trial

British journal of cancer, 2017-03, Vol.116 (7), p.859-863

2017

Volltextzugriff (PDF)

Targeting anthracyclines in early breast cancer: new candidate predictive biomarkers emerge

Oncogene, 2010-09, Vol.29 (38), p.5231-5240

2010

Volltextzugriff (PDF)

KRAS Mutations in Canine and Feline Pancreatic Acinar Cell Carcinoma

Journal of comparative pathology, 2016-07, Vol.155 (1), p.24-28

2016

Volltextzugriff (PDF)

HER2 testing for breast carcinoma: recommendations for rapid diagnostic pathways in clinical practice

Journal of clinical pathology, 2014-02, Vol.67 (2), p.161-167

2014

Volltextzugriff (PDF)

In situ quantification of HER2–protein tyrosine kinase 6 (PTK6) protein–protein complexes in paraffin sections from breast cancer tissues

British journal of cancer, 2010-08, Vol.103 (5), p.663-667

2010

Volltextzugriff (PDF)

Regulation and function of the extracellular matrix protein tenascin-C in ovarian cancer cell lines

British Journal of Cancer, 1999-05, Vol.80 (5-6), p.685-692

1999

Volltextzugriff (PDF)

1 – 25 von 5.958

Suche als RSS-Feed

Aktive Filter

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(5.227)
Mit Volltextzugriff
(5.090)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(3.090)
Life Sciences & Biomedicine
(2.182)
Humans
(1.460)
Biological And Medical Sciences
(972)
Physics
(790)
Physical Sciences
(773)
Animals
(751)
Medical Sciences
(722)
Female
(714)
Male
(676)
Adult
(361)
Technology
(317)
Fundamental And Applied Biological Sciences. Psychology
(304)
High Energy Physics - Experiment
(296)
Chemistry
(287)
Surgery
(268)
Exact Sciences And Technology
(266)
Middle Aged
(246)
Oncology
(230)
Mice
(225)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(2.573)
IngentaConnect
(2.149)
MEDLINE
(2.097)
Single Journals
(1.892)
Journals@Ovid Complete
(1.688)
ScienceDirect Journals (5 years ago - present)
(1.242)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(1.034)
IngentaConnect Journals
(804)
American Physical Society Journals
(701)
PROLA - Physical Review Online Archive
(638)
Wiley Online Library Journals Frontfile Complete
(637)
Wiley Online Library Full Collection 2018
(453)
Springer journals
(325)
JSTOR
(295)
Oxford journals
(255)
Oxford Journals 2020 Medicine
(173)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(167)
Nature Journals Online
(145)
Taylor & Francis Current Content Access
(139)
Taylor & Francis:Master (3349 titles)
(127)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Physical Review Letters
(482)
Physics Letters. B
(259)
Food And Chemical Toxicology
(218)
Cancer Research
(112)
Physical Review. D, Particles, Fields, Gravitation, And Cosmology
(95)
Blood
(93)
Astronomy And Astrophysics
(92)
Transplantation
(87)
Physical Review. D
(83)
Journal Of Clinical Oncology
(56)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(33)
... seit 90 Tagen
(89)

Menü

Weitere Dienste

Einstellungen

The BIG 2.04 MRC/EORTC SUPREMO Trial: pathology quality assurance of a large phase 3 randomised international clinical trial of postmastectomy radiotherapy in intermediate-risk breast cancer

Observer variation in immunohistochemical analysis of protein expression, time for a change?

Prognostic value of protein tyrosine kinase 6 (PTK6) for long-term survival of breast cancer patients

Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer

HER2 Gene Amplification in Breast Cancer: A Rogues' Gallery of Challenging Diagnostic Cases: UKNEQAS Interpretation Guidelines and Research Recommendations

HER2 testing in the UK: further update to recommendations

Phosphorylation of the androgen receptor is associated with reduced survival in hormone-refractory prostate cancer patients

Cardiac safety, efficacy, and correlation of serial serum HER2-extracellular domain shed antigen measurement with the outcome of the combined trastuzumab plus CMF in women with HER2-positive metastatic breast cancer: results from the EORTC 10995 phase II study

A UK NEQAS ISH Multicenter Ring Study Using the Ventana HER2 Dual-Color ISH Assay

PTK (protein tyrosine kinase)-6 and HER2 and 4, but not HER1 and 3 predict long-term survival in breast carcinomas

Time dependence of biomarkers: non-proportional effects of immunohistochemical panels predicting relapse risk in early breast cancer

Chromogenic In Situ Hybridization: A Multicenter Study Comparing Silver In Situ Hybridization With FISH

Tamoxifen resistance in early breast cancer: statistical modelling of tissue markers to improve risk prediction

Lymphocyte density determined by computational pathology validated as a predictor of response to neoadjuvant chemotherapy in breast cancer: secondary analysis of the ARTemis trial

Multimodal Biomarkers That Predict the Presence of Gleason Pattern 4: Potential Impact for Active Surveillance

Disease-free and overall survival at 3.5 years for neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide, for women with HER2 negative early breast cancer: ARTemis Trial

Genetic alterations of CCND1 and EMSY in breast cancers

Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer

HER2 testing in the UK: recommendations for breast and gastric in-situ hybridisation methods

Discrepancies in central review re-testing of patients with ER-positive and HER2-negative breast cancer in the OPTIMA prelim randomised clinical trial

Targeting anthracyclines in early breast cancer: new candidate predictive biomarkers emerge

KRAS Mutations in Canine and Feline Pancreatic Acinar Cell Carcinoma

HER2 testing for breast carcinoma: recommendations for rapid diagnostic pathways in clinical practice

In situ quantification of HER2–protein tyrosine kinase 6 (PTK6) protein–protein complexes in paraffin sections from breast cancer tissues

Regulation and function of the extracellular matrix protein tenascin-C in ovarian cancer cell lines

Aktive Filter

Suchergebnisse filtern